At the virtual ASMS 2020 Reboot conference, Bruker Corporation today announces a major advance in matrix-assisted laser desorption ionization (MALDI) with the launch of the world’s first commercial ...
Bruker said today that it launched the second phase of an ongoing collaboration with SISCAPA Assays Technologies (SAT), intended to exploit the high throughput, robustness, and ease of use of ...
>8000 quantified cell lysate proteins with 40-minute gradients >5000 quantified cell lysate proteins with 4.8-minute separations on Evosep One >5000 quantified proteins in just 10 ng of cell lysate ...
Bruker Launches Library Update for Mycobacteria, Showcases Workflow Optimization tools like MALDI Biotyper Pilot™, MALDI Biotyper Galaxy™ and novel MSBL Software for MALDI-based Functional Resistance ...
The US Food and Drug Administration (FDA) has authorized use of the Bruker Maldi Biotyper CA system (Bruker Daltonik GmbH) to identify Candida auris, an emerging and often multidrug-resistant fungus ...
Mass spectrometry has long been recognized as one of the leading analytical tools for the rapid characterization of biological macromolecules. The imaging function of mass spectrometry combines the ...
The firm bought selected assets in Glasgow, UK for the development, validation and commercialization of molecular assays for applications in microbiology. It includes lab infrastructure and IP in the ...
The US Food and Drug Administration authorized the first test to identify the emerging pathogen Candida auris (C. auris), which can cause serious infections in hospitalized patients. Specifically, the ...
MALDI-2 Increases Small Molecule Sensitivity by One or Two Orders of Magnitude New prm-PASEF Workflow for Translational 4D Proteomics Large-Scale, High-Precision Peptide CCS Measurements for Deep ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback